Review
doi: 10.1023/B:JICE.0000011342.26830.5f.
Why is warfarin underutilized in patients with atrial fibrillation?
Affiliations
- PMID: 14739736
- DOI: 10.1023/B:JICE.0000011342.26830.5f
Item in Clipboard
Review
Why is warfarin underutilized in patients with atrial fibrillation?
J Interv Card Electrophysiol.
2004.
No abstract available
Similar articles
-
The risks and benefits of antithrombotic therapy in chronic atrial fibrillation.Med J Aust. 1996 May 20;164(10):624-6. doi: 10.5694/j.1326-5377.1996.tb122211.x. Med J Aust. 1996. PMID: 8637471 Review.
-
Anticoagulation and atrial fibrillation. Putting the results of clinical trials into practice.West J Med. 1995 Aug;163(2):145-52. West J Med. 1995. PMID: 7571562 Free PMC article.
-
Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.Thromb Haemost. 2008 Jul;100(1):14-5. doi: 10.1160/TH08-06-0344. Thromb Haemost. 2008. PMID: 18612531 No abstract available.
-
Barriers to the use of warfarin: potential solutions.J Interv Card Electrophysiol. 2004;10 Suppl 1:17-20. doi: 10.1023/B:JICE.0000011341.67214.2e. J Interv Card Electrophysiol. 2004. PMID: 14739735 No abstract available.
-
The need for new oral anticoagulants in clinical practice.J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. J Cardiovasc Med (Hagerstown). 2009. PMID: 19571764 Review.
Cited by
-
Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice.J Thromb Thrombolysis. 2007 Aug;24(1):65-72. doi: 10.1007/s11239-006-0002-8. Epub 2007 Jan 27. J Thromb Thrombolysis. 2007. PMID: 17260164
-
Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.Clin Cardiol. 2013 Mar;36(3):166-71. doi: 10.1002/clc.22077. Epub 2012 Nov 14. Clin Cardiol. 2013. PMID: 23151816 Free PMC article.
-
Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.Chem Res Toxicol. 2010 May 17;23(5):939-45. doi: 10.1021/tx1000283. Chem Res Toxicol. 2010. PMID: 20429590 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical